Financial Performance - The company's revenue for Q1 2022 was ¥273,059,493.05, a decrease of 10.34% compared to ¥304,562,930.72 in the same period last year[3] - Net profit attributable to shareholders was ¥41,315,570.66, down 17.95% from ¥50,354,541.59 year-on-year[3] - The basic earnings per share decreased by 16.67% to ¥0.20 from ¥0.24 in the previous year[3] - Total operating revenue for Q1 2022 was CNY 273,059,493.05, a decrease of 10.4% compared to CNY 304,562,930.72 in the same period last year[16] - Net profit for Q1 2022 was CNY 40,493,126.29, a decline of 18.7% from CNY 49,766,068.29 in Q1 2021[17] - The net profit attributable to the parent company for Q1 2022 was ¥41,315,570.66, a decrease of 17.4% compared to ¥50,354,541.59 in Q1 2021[18] - The company’s total comprehensive income for Q1 2022 was ¥40,493,126.29, compared to ¥49,766,068.29 in Q1 2021, representing a decrease of 18.7%[18] Assets and Liabilities - Total assets increased by 6.45% to ¥1,381,735,829.13 from ¥1,298,015,757.68 at the end of the previous year[3] - The company's total assets as of March 31, 2022, amounted to CNY 1,381,735,829.13, an increase from CNY 1,298,015,757.68 at the beginning of the year[13] - Current assets totaled CNY 943,216,418.91, up from CNY 862,051,810.55 at the start of the year, reflecting a growth of 9.4%[12] - Total liabilities rose to CNY 266,715,542.66 from CNY 226,338,562.29, indicating an increase of 17.9%[14] - Shareholders' equity increased to CNY 1,115,020,286.47 from CNY 1,071,677,195.39, reflecting a growth of 4.0%[14] Cash Flow - The net cash flow from operating activities was ¥48,676,726.92, an increase of 2.52% compared to ¥47,480,592.19 in the same period last year[3] - Total cash inflow from operating activities was ¥179,738,104.49, compared to ¥224,311,621.79 in the previous year, indicating a decline of 19.8%[19] - Cash outflow from operating activities totaled ¥131,061,377.57, down from ¥176,831,029.60 in Q1 2021, reflecting a decrease of 25.9%[19] - The net cash flow from investing activities was -¥55,399,655.19, an improvement from -¥174,922,726.29 in the same period last year[21] - The cash and cash equivalents at the end of Q1 2022 were ¥67,851,976.65, compared to ¥52,875,611.27 at the end of Q1 2021, showing an increase of 28.3%[21] - The company reported cash inflow from other investment activities of ¥118,151,169.44 in Q1 2022[21] - The total cash outflow from investing activities was ¥173,550,824.63, down from ¥283,161,269.34 in Q1 2021[21] Operational Metrics - The weighted average return on equity decreased to 3.86% from 5.15% year-on-year, a decline of 1.29%[3] - Accounts receivable increased by 119.25% to ¥81,005,689.26 from ¥36,945,885.96 at the end of the previous year, mainly due to seasonal characteristics of business activities[8] - The company reported a significant increase in prepayments by 71.96% to ¥23,586,981.29, attributed to higher material prepayments[8] - The company experienced a 6138.38% increase in non-operating expenses, amounting to ¥5,494,952.65, primarily due to temporary production line shutdowns[8] - Total operating costs for Q1 2022 were CNY 231,543,723.69, down 10.9% from CNY 259,931,567.69 in Q1 2021[17] - Research and development expenses for Q1 2022 were CNY 13,204,159.61, up from CNY 10,301,078.18 in Q1 2021, indicating a 28.0% increase[17] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 17,016[10] - The basic and diluted earnings per share for Q1 2022 were both ¥0.20, down from ¥0.24 in the same period last year[18]

Financial Performance - The company's revenue for Q3 2021 reached ¥305,006,576.37, representing a year-on-year increase of 29.68%[3] - The net profit attributable to shareholders decreased by 10.97% to ¥36,052,651.21 for the same period[3] - The net profit after deducting non-recurring gains and losses was ¥30,381,163.83, down 13.59% year-on-year[3] - The basic earnings per share for Q3 2021 was ¥0.1709, a decrease of 11.17% compared to the same period last year[3] - The total operating revenue for the third quarter was CNY 934,802,422.70, an increase from CNY 619,358,290.64 in the previous period[23] - The net profit for the quarter reached CNY 121,348,046.93, up from CNY 93,919,788.13 year-over-year, indicating a growth of approximately 29.2%[24] - Earnings per share (EPS) increased to CNY 0.5842 from CNY 0.4559, representing a growth of about 28.2%[25] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,350,172,143.91, an increase of 15.77% compared to the end of the previous year[3] - As of September 30, 2021, total assets reached CNY 1,350,172,143.91, an increase from CNY 1,166,236,014.48 at the end of 2020, reflecting a growth of approximately 15.7%[19] - The company's current assets amounted to CNY 912,878,587.67, up from CNY 783,641,666.28, indicating a growth of about 16.5% year-over-year[20] - The total liabilities increased to CNY 307,290,783.92 from CNY 186,534,351.56, reflecting a rise in financial obligations[24] - The total liabilities as of September 30, 2021, were not explicitly stated but included short-term borrowings of CNY 30,000,000.00, a significant increase from CNY 100,036.25 previously[20] Cash Flow - The company's operating cash flow for the year-to-date was ¥108,230,153.55, up 58.19%[3] - The cash flow from operating activities generated a net amount of CNY 108,230,153.55, compared to CNY 68,415,916.74 in the previous period, showing a substantial increase[27] - The net cash flow from investment activities was -206,936,704.88 CNY, compared to -242,082,012.00 CNY in the previous year, indicating an improvement of approximately 14.4%[28] - Cash inflow from financing activities totaled 41,009,984.00 CNY, an increase from 34,200,500.00 CNY year-over-year, representing a growth of about 19.5%[28] - The ending balance of cash and cash equivalents was 61,335,558.99 CNY, a significant decrease from 14,871,330.86 CNY year-over-year[28] Research and Development - Research and development expenses for the first nine months were ¥33,997,011.03, reflecting a 52.85% increase due to enhanced project efforts[10] - Research and development expenses for the quarter were CNY 33,997,011.03, up from CNY 22,242,645.35, indicating a focus on innovation[23] - A framework agreement for comprehensive technical cooperation was signed with the China Daily Chemical Research Institute, enhancing R&D capabilities[16] Production and Operations - The company entered trial production for the 10,000 tons/year terminal amino polyether project and the 22,700 tons/year polyether project, both part of the Huai'an production base[16] - The company faced temporary production halts due to government-mandated power restrictions but resumed operations on October 8, 2021[17] - A cooperation framework agreement was established for a new project with an annual output of 40,000 tons of polyether amine and 42,000 tons of polyether[17] Shareholder Equity - The total equity attributable to shareholders reached CNY 1,019,087,166.01, compared to CNY 954,132,725.07 in the previous period, showing a growth in shareholder value[24] - The company reported a total of 457,519 restricted shares, with 372,400 shares released during the period, indicating active management of executive stock incentives[15] Other Financial Metrics - The total operating costs amounted to CNY 827,599,855.77, compared to CNY 538,690,251.68 in the prior period, reflecting a significant rise in costs[23] - The deferred income decreased slightly to CNY 34,309,443.29 from CNY 35,215,182.23, indicating stability in future revenue recognition[24] - The cash inflow from investment activities was 283,468,410.87 CNY, compared to 242,704,124.33 CNY in the previous year, marking an increase of approximately 16.8%[28] Audit and Reporting - The company did not undergo an audit for the third quarter report[30] - The report was released on October 26, 2021, and is the first to apply the new leasing standards[29]

Financial Performance - The company reported a revenue of 300 million RMB for the first half of 2021, representing a 15% increase compared to the same period last year[15]. - The net profit attributable to shareholders was 50 million RMB, up 20% year-on-year[15]. - The company's operating revenue for the reporting period was ¥629,795,846.33, representing a year-on-year increase of 63.94% compared to ¥384,161,882.39 in the same period last year[21]. - The net profit attributable to shareholders was ¥87,070,139.58, up 57.17% from ¥55,398,849.73 in the previous year[21]. - The basic earnings per share increased to ¥0.54, a rise of 45.95% compared to ¥0.37 in the same period last year[21]. - The company reported a total profit of ¥99,279,955.90 for the first half of 2021, up 61.3% from ¥61,519,725.92 in the same period of 2020[193]. - The company reported a revenue of 500 million for the first half of 2021, reflecting a year-on-year growth of 10% compared to the same period in 2020[81]. - The company reported a revenue of 1,500 million with a growth rate of 3.90% for the first half of 2021[83]. - The company reported a total revenue of 59,500 million with a net profit of 1,721 million, reflecting a significant performance in the first half of 2021[89]. Research and Development - The company plans to invest 10 million RMB in R&D for new product development in the next fiscal year[15]. - The company is developing new eco-friendly materials, with a projected launch date in Q4 2021[15]. - The company's R&D investment increased by 109.32% to ¥22,524,970.62, up from ¥10,761,029.07, reflecting enhanced efforts in research projects[53]. - The company has a professional R&D team of 96 members, enabling timely product development in response to market demands[50]. - The company is investing in research and development, allocating 300 million for new technology initiatives[84]. Market Expansion and Strategy - The company has outlined a market expansion strategy targeting Southeast Asia, aiming for a 30% market share by 2025[15]. - The company plans to expand its market presence by launching new products in the second half of 2021, targeting a 15% increase in market share[82]. - The company is focusing on expanding its market share in the Asia-Pacific region[86]. - The company is exploring potential mergers and acquisitions to enhance its growth strategy[86]. Financial Management and Investments - The total amount of raised funds is CNY 2,182.2 million, with CNY 293.41 million invested during the reporting period[68]. - The company has engaged in entrusted financial management, with a total of CNY 30 million in financial products, including CNY 27.5 million from self-owned funds and CNY 2.5 million from raised funds[77]. - The company has a total of 177.67 million CNY in realized gains from its financial investments during the reporting period[78]. - The company is committed to maintaining a diversified investment portfolio to mitigate risks associated with market fluctuations[79]. Environmental and Safety Compliance - The company is committed to maintaining compliance with environmental regulations and standards[114]. - The company has implemented a wastewater treatment system to ensure compliance with discharge standards[114]. - The company has established an emergency response plan for environmental incidents, which has been reviewed and filed[119]. - The company has not experienced any major safety or environmental incidents during the reporting period[119]. Shareholder and Corporate Governance - The company held three shareholder meetings during the reporting period, with investor participation rates of 40.32%, 44.66%, and 39.42% respectively[104][105]. - The company plans not to distribute cash dividends or issue bonus shares for the half-year period[106]. - The company approved a restricted stock incentive plan, granting 1,937,600 shares to 96 individuals[159]. - The company confirmed the retirement of a key technical personnel, ensuring a smooth transition without negative impact on R&D or operations[153]. Risk Factors - The company faces risks from the COVID-19 pandemic and macroeconomic fluctuations, which could lead to reduced downstream demand and overcapacity, negatively impacting profitability[95]. - The company is exposed to international trade friction risks, particularly with the U.S., which has imposed tariffs on Chinese goods, potentially affecting the export of its functional silane products[99]. - Environmental protection and safety risks are significant, as the company deals with hazardous materials, and any incidents could adversely affect operations and compliance with increasing environmental standards[98].

Financial Performance - The company's revenue for Q1 2021 was CNY 304,562,930.72, representing an increase of 81.86% compared to CNY 167,469,781.07 in the same period last year[7]. - Net profit attributable to shareholders was CNY 50,354,541.59, a significant increase of 154.75% from CNY 19,765,999.98 year-on-year[7]. - The net profit after deducting non-recurring gains and losses reached CNY 45,639,469.20, up 166.03% from CNY 17,155,912.79 in the previous year[7]. - The basic earnings per share (EPS) was CNY 0.33, reflecting a growth of 153.85% compared to CNY 0.13 in the same quarter last year[7]. - The total operating revenue for the first quarter of 2021 reached ¥304,562,930.72, compared to ¥167,469,781.07 in the previous period, representing an increase of approximately 81.8%[47]. - Net profit for the first quarter was ¥49,766,068.29, compared to ¥19,597,029.46 in the same period last year, reflecting an increase of approximately 153.5%[49]. - The company reported a total profit of ¥54,284,280.97 for the first quarter, compared to ¥22,066,634.75 in the previous year, an increase of approximately 145.0%[49]. Assets and Liabilities - The total assets at the end of the reporting period were CNY 1,308,317,274.11, an increase of 12.18% from CNY 1,166,236,014.48 at the end of the previous year[7]. - The company's total assets as of March 31, 2021, were ¥1,134,925,791.67, up from ¥1,039,972,779.00 at the end of 2020, marking an increase of about 9.1%[44]. - The total liabilities of the company were CNY 281,020,536.77 as of March 31, 2021, compared to CNY 186,534,351.56 at the end of 2020, which is an increase of approximately 50.5%[40]. - Current liabilities increased to ¥175,440,358.20 from ¥107,881,363.74, representing a growth of approximately 62.5%[45]. Cash Flow - The net cash flow from operating activities was CNY 47,480,592.19, showing a 10.58% increase from CNY 42,938,338.62 in the same period last year[7]. - The cash flow from operating activities generated a net amount of ¥47,480,592.19, up from ¥42,938,338.62 in the previous period, reflecting a growth of approximately 12%[57]. - The company's cash and cash equivalents decreased to CNY 52,875,611.27 from CNY 180,416,364.93, a decline of approximately 70.7%[37]. - The ending balance of cash and cash equivalents was ¥41,668,452.61, down from ¥159,848,738.46 at the beginning of the period[61]. Research and Development - Research and development expenses increased by 89.19% to ¥10.30 million in Q1 2021, driven by an increase in the number and progress of R&D projects[16]. - The company has 26 ongoing R&D projects aimed at optimizing existing products and developing new ones[17]. - The company plans to invest in expanding its R&D capabilities to enhance product innovation and maintain competitive advantage[21]. - Research and development expenses for the first quarter were ¥10,301,078.18, up from ¥5,444,880.23, indicating an increase of approximately 89.5%[48]. Investments and Fundraising - The company reported a total fundraising amount of 21,822 million yuan, with 631.74 million yuan invested in the current quarter[27]. - Cumulative investment from fundraising reached 14,907.94 million yuan, with 18.36% of the funds having been repurposed[27]. - The project for producing 15,000 tons of alkyl glycosides has achieved 90.46% of its investment target, totaling 5,337.4 million yuan[27]. - The total investment for the R&D building project has increased from 40.06 million to 109.18 million, with 40.06 million sourced from previous fundraising and 69.12 million from company self-funding[28]. Risks and Challenges - Risks include intensified industry competition and potential quality control issues, which could adversely affect business operations and reputation[20]. - The company faces risks related to the transportation of hazardous chemicals, which could impact raw material supply and daily operations[22]. - The retirement of a core technical staff member may affect the company's technological capabilities[23]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 11,317[11]. - The company has not reported any overdue commitments from major stakeholders during the reporting period[25]. - There are no non-operational fund occupations by controlling shareholders or related parties reported during the period[31]. Corporate Governance - The company has successfully renewed its high-tech enterprise certification, allowing it to continue enjoying a 15% corporate income tax rate until 2022[23]. - The company has not reported any violations regarding external guarantees during the reporting period[30]. - The company has conducted investor relations activities, discussing operational conditions and market management with institutional investors[32].

Financial Performance - The company's operating revenue for 2020 was ¥900,255,186.07, representing an increase of 11.85% compared to ¥804,898,109.37 in 2019 [20]. - The net profit attributable to shareholders for 2020 was ¥137,309,895.84, a growth of 44.05% from ¥95,324,016.84 in 2019 [20]. - The net profit after deducting non-recurring gains and losses was ¥124,032,991.03, which is a 57.99% increase from ¥78,505,926.53 in 2019 [20]. - The basic earnings per share for 2020 was ¥0.91, up 44.44% from ¥0.63 in 2019 [20]. - The total assets at the end of 2020 amounted to ¥1,166,236,014.48, reflecting a 13.72% increase from ¥1,025,548,438.93 at the end of 2019 [20]. - The company reported a net cash flow from operating activities of ¥111,776,621.65, which is a 7.70% increase compared to ¥103,789,952.21 in 2019 [20]. - The company's total operating revenue for 2020 was ¥900,255,186.07, representing an increase of 11.85% compared to ¥804,898,109.37 in 2019 [54]. - The net profit attributable to the parent company was 137.31 million yuan, reflecting a growth of 44.05% compared to the previous year [43]. Dividend Distribution - The company plans to distribute a cash dividend of 4 RMB per 10 shares to all shareholders, based on a total of 15,067,300 shares [6]. - The cash dividend for 2020 represents 43.89% of the net profit attributable to the shareholders of the listed company [128]. - The company has maintained a consistent dividend policy over the past three years, with cash dividends of 1.10 RMB, 1.50 RMB, and 4 RMB per 10 shares for 2018, 2019, and 2020 respectively [127]. - The total distributable profit for the year was 436,201,237.15 RMB, with the cash dividend accounting for 100% of the profit distribution [126]. - The cash dividend distribution plan was approved at the annual general meeting held on May 22, 2020 [125]. Risk Management - The company emphasizes the importance of risk awareness regarding raw material supply and price fluctuations, exchange rate risks, and environmental protection [6]. - The company has disclosed potential risks in its future development outlook section, which investors should pay attention to [6]. - The company recognizes the risk of intensified industry competition and is preparing to address potential challenges in quality control and product liability [117]. - The company faces risks related to safety production and the transportation of hazardous chemicals, which require high operational standards [118]. - The company is actively monitoring market trends and potential risks to inform its future development strategies [121]. Research and Development - The company focuses on continuous R&D investment, enhancing its capabilities in new materials and production automation [34]. - Research and development investment for 2020 was 29.91 million yuan, with a total of 35 patents filed, including 29 invention patents [43]. - The company has formed a collaborative R&D system with universities and research institutions, improving its innovation efficiency [40]. - The company is currently in the process of developing new products and technologies, although specific details were not disclosed in the provided content [84]. - The company is committed to innovation-driven and sustainable development strategies in line with national policies [104]. Market Presence and Strategy - The company has a diverse customer base across various industries, including polyurethane, textiles, and electronics, indicating strong market presence [29]. - The company achieved an international market export revenue of 10.19% of its main business income in 2020 [34]. - The company is expanding its market presence in Southeast Asia, targeting a 10% market share by the end of the next fiscal year [135]. - The company plans to enhance its production management to control operational costs and improve economic efficiency [115]. - The company aims to enhance its competitive strength and profitability, striving for dual improvements in revenue and profit levels [159]. Compliance and Governance - The company’s financial report is guaranteed to be true, accurate, and complete by its board of directors and management [5]. - The company has adhered to the guidelines set by the China Securities Regulatory Commission regarding profit distribution policies [125]. - The company will publicly disclose specific reasons for any failure to fulfill commitments made in the prospectus, along with an apology to shareholders and the public [161]. - The company has established a framework to ensure compliance with the commitments made during its initial public offering [162]. - The company confirmed that all commitments made to minority shareholders were fulfilled on time [171]. Environmental and Safety Management - The company has established a dedicated safety and environmental protection department, with no administrative penalties reported during the period [46]. - The company is focusing on green transformation in the chemical industry, promoting clean production and resource recycling [106]. - Environmental protection costs are increasing due to stricter pollution control standards, which may impact the company's normal operations as production scales up [119]. - The company has improved its production processes to control pollutants, but the increasing scale of production may lead to higher emissions of waste materials [119]. - The company has faced increased safety review requirements for projects involving hazardous materials following a major chemical accident in Jiangsu province [93].

Financial Performance - Net profit attributable to shareholders increased by 34.19% to CNY 40,495,986.81 for the reporting period[7] - Operating revenue for the reporting period was CNY 235,196,408.25, reflecting a 14.79% increase year-on-year[7] - The net profit after deducting non-recurring gains and losses was CNY 35,159,369.14, up 26.92% compared to the same period last year[7] - Basic earnings per share rose by 34.10% to CNY 0.2694 for the reporting period[7] - The weighted average return on net assets increased to 4.47%, up 0.68% from the previous year[7] - The net profit for Q3 2020 was CNY 39,722,548.05, representing a 32.4% increase from CNY 30,042,944.87 in Q3 2019[43] - The company's total operating revenue for the current period is CNY 619,358,290.64, an increase from CNY 598,786,265.45 in the previous period, representing a growth of approximately 0.96%[49] - The net profit for the current period is CNY 93,919,788.13, compared to CNY 66,870,759.77 in the previous period, indicating a significant increase of approximately 40.5%[51] Assets and Liabilities - Total assets increased by 7.91% to CNY 1,106,646,700.12 compared to the end of the previous year[7] - Current assets totaled CNY 753,369,510.78, compared to CNY 699,466,811.94 at the end of 2019, reflecting a growth of approximately 7.7%[33] - The company's equity stood at CNY 953,352,880.14, up from CNY 880,360,213.95 at the end of 2019[35] - The total liabilities as of September 30, 2020, were CNY 138,197,000.91, an increase from CNY 127,045,714.91, reflecting a rise of 8.5%[39] - Total liabilities amounted to CNY 145,188,224.98, with current liabilities at CNY 117,527,397.63 and non-current liabilities at CNY 27,660,827.35[68] Cash Flow - The net cash flow from operating activities was negative at CNY -33,510,435.81, a decrease of 277.58% compared to the same period last year[7] - The cash flow from operating activities generated a net amount of CNY 68,415,916.74, down 20% from CNY 85,465,579.72 in the previous period[59] - The net cash flow from operating activities for the period was ¥46,498,027.04, a decrease of 66.3% compared to ¥137,580,378.71 in the previous period[61] - Total cash inflow from investment activities was ¥193,209,170.85, while cash outflow was ¥402,886,350.03, resulting in a net cash flow of -¥209,677,179.18, worsening from -¥123,534,490.02 in the previous period[61] Shareholder Information - The total number of shareholders at the end of the reporting period was 12,021[10] - The largest shareholder, Yu Zizhou, holds 24.29% of the shares, totaling 36,597,117 shares[10] - The company completed the repurchase and cancellation of 7,000 restricted stocks, reducing total shares from 15,068,000 to 15,067,300[21] Government Subsidies - The company received government subsidies amounting to CNY 2,524,552.94, which are closely related to its business operations[8] - The company received a government subsidy of ¥300,000 for the R&D building project on September 14, 2020[22] Research and Development - Research and development expenses for Q3 2020 were CNY 11,481,616.28, which is a substantial increase of 94.5% compared to CNY 5,906,918.89 in Q3 2019[42] - Research and development expenses for the current period amount to CNY 22,242,645.35, an increase from CNY 18,647,224.74 in the previous period, representing a growth of about 19%[49] Other Financial Metrics - The company's financial activities included a 59.57% increase in cash payments related to investment activities, totaling ¥433,000,000.00 compared to ¥271,360,000.00 in the previous year[19] - The company's income tax payable increased by 200.93% to ¥10,122,790.54 from ¥3,363,821.21, mainly due to an increase in corporate income tax[19] - The company reported a profit before tax of CNY 44,797,555.79, compared to CNY 34,271,307.78 in the previous year, indicating a growth of 30.5%[43]

Corporate Governance - The legal representative of the company is Yu Zizhou[13]. - All directors attended the board meeting to review the report[4]. - The company has not changed its registered address or contact information during the reporting period[15]. - The company has not reported any changes in its information disclosure practices during the reporting period[16]. - The company has not engaged in any related party transactions during the reporting period[98]. - The company did not experience any major litigation or arbitration matters during the reporting period[89]. - The company has not reported any major product liability claims or legal disputes since its establishment[77]. - The company has not engaged in derivative investments or entrusted loans during the reporting period[70][71]. - The company has not sold any major assets or equity during the reporting period[72][73]. - The company did not have any penalties or rectification situations during the reporting period[90]. - The company has not reported any changes in fundraising projects during the reporting period[61]. - The company did not experience any changes in its controlling shareholder or actual controller during the reporting period[134]. - The company has not engaged in any repurchase transactions among its top 10 shareholders during the reporting period[133]. - The company has not reported any changes in its board of directors, supervisors, or senior management during the reporting period[144]. Financial Performance - The company's operating revenue for the reporting period was ¥384,161,882.39, a decrease of 2.47% compared to the same period last year[18]. - Net profit attributable to shareholders increased by 49.31% to ¥55,398,849.73, while the net profit after deducting non-recurring gains and losses rose by 66.14% to ¥48,659,622.11[18]. - Basic earnings per share increased by 48.79% to ¥0.3681, and diluted earnings per share rose by 48.87% to ¥0.3680[18]. - Total assets at the end of the reporting period reached ¥1,092,723,380.72, reflecting a growth of 6.55% compared to the end of the previous year[18]. - The company's cash and cash equivalents decreased by 130.76 million yuan, a decline of 67.76%, primarily due to investments in financial products[32]. - The company reported a net profit of 1,300 million CNY with an annualized return rate of 4.80% for its financial products[64]. - The company achieved a net income of 14.7 million, reflecting a 13.56% increase compared to the previous period[67]. - The company reported a total comprehensive income of 37,787,139.00 RMB for the first half of 2020[184]. Research and Development - Research and development investment for the first half of 2020 was 10.76 million yuan, with a total of 40 patents held, including 28 invention patents[39][40]. - The company focuses on R&D in fine chemical new materials, with core technologies in some products being at a leading domestic level[31]. - The company plans to invest in the expansion of its technology research and development center to enhance product innovation capabilities[78]. - The company is focusing on developing new technologies to enhance product offerings and meet market demands[68]. Market and Sales - The company emphasizes a direct sales model and customer-centric service to enhance market penetration and customer relationships[28]. - The international market export revenue accounted for 9.91% of the main business income in the first half of 2020, highlighting the company's efforts in market expansion[31]. - The company aims to enhance its market share and brand influence through optimized marketing channels and increased brand promotion[40]. - The company exported products worth 38.06 million yuan in the first half of 2020, expanding its customer base internationally[34]. Environmental Management - The company is classified as a key pollutant discharge unit by environmental protection authorities[111]. - Total COD emissions were reported at 2.848 tons per year, with no exceedance of discharge standards[111]. - The company has implemented strict environmental protection measures, ensuring all pollution control facilities are operational and compliant with environmental impact assessments[115]. - The company has engaged third-party services for soil and groundwater monitoring, ensuring compliance with environmental standards[119]. - The company has established a contract with a qualified hazardous waste disposal unit for the proper handling of hazardous waste generated during production[119]. Financial Management - The company plans not to distribute cash dividends, issue bonus shares, or increase capital from reserves[5]. - The total amount of raised funds was CNY 21,822,000, with CNY 167,210 used in the reporting period[56]. - The company has a total of CNY 11,639,090 remaining in raised funds as of June 30, 2020, including investment income and bank interest[56]. - The company is expected to maintain a low-risk investment strategy for its financial products in 2020[66]. - The company is actively managing its financial assets to ensure a stable return amidst market fluctuations[66]. Share Capital and Ownership - The company’s total share capital decreased from 150,682,000 shares to 150,680,000 shares due to the repurchase and cancellation of restricted stock[93]. - The largest shareholder, Yu Zizhou, holds 24.91% of the shares, amounting to 37,539,617 shares[132]. - A total of 60,493,766 restricted shares were released during the reporting period, leaving 40,242,169 restricted shares[130]. - The company’s registered capital changed from RMB 150,682,000 to RMB 150,680,000 following the cancellation of restricted stock[93]. Operational Efficiency - The company is in the process of relocating its R&D office to a more advantageous location to enhance operational efficiency and market competitiveness[59]. - The company has initiated a strategy to enhance operational efficiency and optimize resource allocation[68]. - The company aims to improve its overall operational management and market competitiveness through the expansion of its R&D facilities[59]. Risk Management - The company has detailed the risks it faces and corresponding countermeasures in the report[4]. - The company faces risks from intensified industry competition, particularly in the surfactant market, which may affect its market position[76]. - Environmental protection and safety production risks are significant concerns due to the nature of the chemicals handled by the company[79].

[Company Overview and Shareholder Information](index=3&type=section&id=Section%202%20Company%20Basic%20Information) This section provides an overview of the company's key financial data, shareholder structure, and changes in restricted shares during the reporting period [Key Accounting Data and Financial Indicators](index=3&type=section&id=I.%20Key%20Accounting%20Data%20and%20Financial%20Indicators) In Q1 2020, the company's total operating revenue decreased by 18.26% year-over-year, but net profit attributable to shareholders increased by 35.54%, and non-recurring net profit surged by 67.25%, driven by higher gross profit and investment income, with operating cash flow turning positive Q1 2020 Key Financial Indicators | Indicator | Current Period | Prior Period | Year-over-Year Change | | :--- | :--- | :--- | :--- | | Total Operating Revenue (RMB) | 167,469,781.07 | 204,883,868.21 | -18.26% | | Net Profit Attributable to Shareholders (RMB) | 19,765,999.98 | 14,583,323.29 | 35.54% | | Net Profit Attributable to Shareholders Excluding Non-recurring Items (RMB) | 17,155,912.79 | 10,257,700.02 | 67.25% | | Net Cash Flow from Operating Activities (RMB) | 42,938,338.62 | -12,683,453.79 | Not Applicable | | Basic Earnings Per Share (RMB/share) | 0.13 | 0.10 | 30.00% | | Total Assets (RMB) | 1,093,386,528.49 | 1,025,548,438.93 (Prior Year-End) | 6.61% | Q1 2020 Non-recurring Gains and Losses | Item | Amount (RMB) | Explanation | | :--- | :--- | :--- | | Government Grants | 410,246.30 | - | | Investment Income from Financial Assets | 4,417,175.22 | Primarily investment income from wealth management products | | Net Other Non-operating Income/Expenses | -1,773,729.71 | Primarily charitable donations | | **Total** | **2,610,087.19** | - | [Shareholder Information](index=4&type=section&id=II.%20Total%20Shareholders%20and%20Top%20Ten%20Shareholders%20at%20Period%20End) As of the reporting period end, the company had 9,843 common shareholders, with the top ten shareholders collectively holding 51.02% of shares, indicating a relatively concentrated ownership structure, led by Yu Zizhou with a 25.44% stake - At the end of the reporting period, the company had **9,843** common shareholders[11](index=11&type=chunk) Top Ten Shareholders' Holdings | Shareholder Name | Holding Percentage | Number of Shares Held | | :--- | :--- | :--- | | Yu Zizhou | 25.44% | 38,335,317 | | Xu Changsheng | 6.09% | 9,180,205 | | Yang Sixue | 4.62% | 6,956,456 | | Hao Sizhen | 2.63% | 3,962,425 | | Dong Xiaohong | 2.38% | 3,588,744 | | Shi Chenghua | 2.37% | 3,566,887 | | Hao Yun | 2.33% | 3,516,183 | | China-Belgium Direct Equity Investment Fund | 1.87% | 2,820,768 | | Hao Meilin | 1.75% | 2,641,499 | | Jiangsu Gaotou Xinhai Venture Capital Co., Ltd. | 1.54% | 2,318,169 | [Changes in Restricted Shares](index=5&type=section&id=III.%20Changes%20in%20Restricted%20Shares) During the reporting period, the company saw a significant release of restricted shares, totaling 60,486,766 shares, including 47,231,876 shares from initial public offering restrictions and partial executive lock-up shares, reducing the period-end restricted share count to 40,242,169 shares - During the reporting period, due to initial public offering restrictions and executive lock-ups, the company released a total of **60,486,766** restricted shares, reducing the period-end restricted share count from **100,728,935** shares at the beginning of the period to **40,242,169** shares[15](index=15&type=chunk) - The remaining **47,231,876** shares held by **36** shareholders from the initial public offering restrictions were released on February 13, 2020[14](index=14&type=chunk) [Management Discussion and Analysis](index=7&type=section&id=Section%203%20Significant%20Matters) This section provides an in-depth analysis of the company's financial performance, operational highlights, research and development progress, and key risks, along with updates on significant corporate events and the use of raised funds [Analysis of Significant Changes in Financial Position](index=7&type=section&id=I.%20Significant%20Changes%20in%20Key%20Financial%20Data%20and%20Indicators%20and%20Their%20Causes) During the reporting period, several balance sheet items experienced significant changes, with a substantial decrease in monetary funds primarily due to the purchase of wealth management products, leading to a corresponding surge in other current assets, while accounts receivable rose due to sales seasonality and construction in progress increased from ongoing investment in the Huai'an project Key Balance Sheet Item Changes (March 2020 vs. End of 2019) | Item | Change Rate | Primary Reason for Change | | :--- | :--- | :--- | | Monetary Funds | -76.98% | Primarily due to using idle monetary funds to purchase wealth management products | | Accounts Receivable | 84.08% | Primarily due to sales seasonality | | Other Current Assets | 78.47% | Primarily due to increased purchases of wealth management products | | Construction in Progress | 77.35% | Primarily due to increased construction in progress in Huai'an | | Notes Payable | 184.08% | Primarily due to increased issuance of bank acceptance bills | - Investment income surged by **929.14%** year-over-year, primarily due to increased returns from wealth management products[19](index=19&type=chunk) [Operating Review and Outlook](index=7&type=section&id=II.%20Business%20Review%20and%20Outlook) Despite a year-over-year decline in Q1 operating revenue, the company achieved significant net profit growth by improving gross sales margin and investment income, while continuously advancing multiple high-value-added new material R&D projects and addressing risks such as industry competition, quality control, and environmental safety [Operating Performance](index=7&type=section&id=Specific%20Factors%20Driving%20Business%20Revenue%20Changes%20During%20the%20Reporting%20Period) In Q1 2020, the company achieved operating revenue of **RMB 167.47 million**, a year-over-year decrease of **18.26%**, but net profit attributable to the parent company reached **RMB 19.77 million**, a **35.54%** increase year-over-year, primarily driven by higher gross sales margin and investment income from wealth management products - The increase in net profit during the reporting period was primarily due to higher gross sales margin and increased income from wealth management products[20](index=20&type=chunk) [R&D Project Progress](index=7&type=section&id=Progress%20and%20Impact%20of%20Key%20R%26D%20Projects) The company is actively advancing **10** key R&D projects to enhance product competitiveness and added value, with several projects like polyetheramine BS-1 and epoxy-terminated allyl polyether entering pilot-scale production, while polyetheramine gasoline detergents and microchannel reaction synthesis flame retardants are in the lab-scale phase, aiming to fill domestic gaps, innovate technologies, and reduce environmental pollution - The company has multiple R&D projects in the pilot-scale production phase, including the development of **polyetheramine BS-1**, **epoxy-terminated allyl polyether**, and **alcohol ether alkyl glycosides**, aiming to provide data for industrial production and fill domestic gaps[20](index=20&type=chunk)[21](index=21&type=chunk) - Several projects are in the lab-scale phase, focusing on cutting-edge areas such as polyetheramine gasoline detergents, microchannel reaction synthesis technology, and silane-modified polyether silicone rubber, with the goal of enhancing product performance and achieving energy-efficient and safe production[21](index=21&type=chunk)[22](index=22&type=chunk) [Major Suppliers and Customers](index=9&type=section&id=Changes%20and%20Impact%20of%20the%20Company%27s%20Top%205%20Suppliers%20During%20the%20Reporting%20Period) During the reporting period, the concentration of both the top five suppliers and top five customers decreased, with procurement from the top five suppliers falling from **46.72%** to **40.36%**, and sales to the top five customers significantly dropping from **10.6%** to **4.96%**, indicating a more diversified customer and supplier base Changes in Top Five Suppliers and Customers | Item | Current Period | Prior Period | Change | | :--- | :--- | :--- | :--- | | Top Five Suppliers' Procurement Share | 40.36% | 46.72% | -6.36% | | Top Five Customers' Sales Share | 4.96% | 10.6% | -5.64% | [Risk Factors and Countermeasures](index=9&type=section&id=Significant%20Risk%20Factors%20Adversely%20Affecting%20the%20Company%27s%20Future%20Operations) The company faces key operational risks including intensified industry competition, product quality control, new product R&D failure or technological obsolescence, and safety production and environmental protection risks, all of which could adversely impact its business, financial condition, and reputation - Intensified industry competition: The polyetheramine industry attracts new entrants due to high gross margins, while alkyl glycosides face competition from substitutes[23](index=23&type=chunk) - New product R&D and technology substitution risks: The company may lose its technological and market leadership if it fails to accurately grasp industry trends or effectively promote new technologies[25](index=25&type=chunk) - Safety production and environmental risks: The company's production involves hazardous chemicals and high-temperature, high-pressure processes, posing risks of safety accidents and "three wastes" (waste gas, waste water, and industrial residue) emission treatment[26](index=26&type=chunk) [Progress of Significant Matters](index=10&type=section&id=III.%20Analysis%20of%20Progress%2C%20Impact%2C%20and%20Solutions%20for%20Significant%20Matters) During the reporting period, the company made two significant advancements: multiple new projects are under construction at Huai'an Chenhua New Materials Co., Ltd., including polyether, polyetheramine, and flame retardant projects; and on February 13, 2020, the company released most of its pre-IPO restricted shares, with 56,797,732 shares becoming tradable - Multiple new projects are under construction at the Huai'an subsidiary, including **8,000 tons** of polyether, **1,500 tons** of capped polyether, **13,000 tons** of polyetheramine, and **20,000 tons** of flame retardant projects[27](index=27&type=chunk) - On February 13, 2020, a portion of the company's shares issued before its initial public offering were released from restrictions, with **56,797,732** shares becoming tradable, representing **37.6943%** of the company's total share capital[27](index=27&type=chunk)[28](index=28&type=chunk) [Use of Raised Funds](index=11&type=section&id=V.%20Comparison%20Table%20of%20Raised%20Funds%20Usage) As of the reporting period end, cumulative raised funds invested totaled **RMB 114.23 million**, with an investment progress of approximately **52%**, while the "R&D Building Project" lagged due to site changes but has entered the implementation phase, and the company adjusted the location and total investment for the original "R&D Center Expansion Project" to align with new strategic layouts, with unused funds primarily allocated to wealth management products and special accounts Progress of Committed Investment Projects Using Raised Funds | Committed Investment Project | Adjusted Total Investment (RMB 10,000) | Cumulative Investment as of Period End (RMB 10,000) | Investment Progress | | :--- | :--- | :--- | :--- | | Annual Production of 15,000 Tons of Alkyl Glycosides Project | 5,900.45 | 5,179.98 | 87.79% | | Annual Production of 5,000 Tons of Polyetheramine Project | 6,915.55 | 1,242.89 | 17.97% | | R&D Building Project | 4,006 | 0 | 0.00% | | Supplement Working Capital | 5,000 | 5,000 | 100.00% | - The "R&D Building Project" (formerly the R&D Center Expansion Project) experienced delays due to a change in implementation location as the company sought a more advantageous transportation site, but it entered the implementation phase in 2020[30](index=30&type=chunk) - Of the **RMB 116.16 million** in unused raised funds, the majority (**RMB 107.60 million**) was used to purchase various brokerage wealth management products[32](index=32&type=chunk) [Financial Statements and Notes](index=14&type=section&id=Section%204%20Financial%20Statements) This section presents the company's consolidated and parent company financial statements for the first quarter of 2020, including balance sheets, income statements, and cash flow statements, along with explanations for financial statement adjustments and the audit status [Consolidated Financial Statements](index=14&type=section&id=1.%20Consolidated%20Balance%20Sheet) This section presents the company's consolidated balance sheet, income statement, and cash flow statement for Q1 2020, with key data indicating growth in total assets, an increase in total liabilities, and steady growth in owner's equity, while the income statement reflects a trend of declining revenue but increasing profit, and the cash flow statement shows significant improvement in operating cash flow but substantial investment outflows Consolidated Financial Statements Summary (Q1 2020) | Statement Item | Period-End/Current Period Amount (RMB) | | :--- | :--- | | **Balance Sheet** | | | Total Assets | 1,093,386,528.49 | | Total Liabilities | 191,143,602.02 | | Equity Attributable to Parent Company Owners | 874,054,291.87 | | **Income Statement** | | | Total Operating Revenue | 167,469,781.07 | | Total Profit | 22,066,634.75 | | Net Profit Attributable to Parent Company Owners | 19,765,999.98 | | **Cash Flow Statement** | | | Net Cash Flow from Operating Activities | 42,938,338.62 | | Net Cash Flow from Investing Activities | -204,324,098.83 | | Net Increase in Cash and Cash Equivalents | -147,740,624.98 | [Parent Company Financial Statements](index=17&type=section&id=2.%20Parent%20Company%20Balance%20Sheet) This section provides the parent company's balance sheet, income statement, and cash flow statement for Q1 2020, with its financial position and operating results generally consistent with consolidated trends, but specific figures reflecting the parent company's standalone operations [Explanation of Financial Statement Adjustments](index=27&type=section&id=II.%20Explanation%20of%20Financial%20Statement%20Adjustments) In accordance with Ministry of Finance requirements, the company adopted new revenue recognition standards effective January 1, 2020, primarily reclassifying amounts related to sales of goods and services previously in "Advances from Customers" to "Contract Liabilities," with no impact on total assets or net profit - Effective January 1, 2020, the company adopted new revenue recognition standards, reclassifying advances from customers related to sales of goods and services to contract liabilities[67](index=67&type=chunk)[70](index=70&type=chunk) Accounting Standard Change Adjustment Example (Consolidated Statement) | Item | December 31, 2019 | Adjustment Amount | January 01, 2020 | | :--- | :--- | :--- | :--- | | Advances from Customers | 6,192,594.16 | -6,192,594.16 | 0 | | Contract Liabilities | 0 | 6,192,594.16 | 6,192,594.16 | [Audit Opinion](index=31&type=section&id=III.%20Audit%20Report) The company's Q1 2020 report is unaudited - The company's first-quarter report is unaudited[71](index=71&type=chunk)

Financial Performance - The company's operating revenue for 2019 was ¥804,898,109.37, representing a 2.30% increase from ¥786,803,315.11 in 2018[18]. - The net profit attributable to shareholders for 2019 was ¥95,324,016.84, a 10.59% increase compared to ¥86,198,035.33 in 2018[18]. - The net cash flow from operating activities increased by 49.40% to ¥103,789,952.21 in 2019 from ¥69,471,230.08 in 2018[18]. - The total assets at the end of 2019 were ¥1,025,548,438.93, a 14.84% increase from ¥893,032,948.07 at the end of 2018[18]. - The company's basic earnings per share for 2019 was ¥0.63, up 10.53% from ¥0.57 in 2018[18]. - The company reported a total of ¥16,818,090.31 in non-recurring gains and losses for 2019, compared to ¥12,322,850.54 in 2018[25]. - In 2019, the company achieved total operating revenue of CNY 804.90 million, a year-on-year increase of 2.3%[43]. - The net profit attributable to the parent company was CNY 95.32 million, reflecting a growth of 10.59% compared to the previous year[43]. - The company reported a gross margin of 25.87% for the fine chemical new materials sector, a decrease of 2.63% compared to the previous year[52]. - The company reported a total revenue of 1.5 billion RMB for the fiscal year 2019, representing a year-over-year growth of 15%[126]. Dividend Distribution - The company plans to distribute a cash dividend of 1.5 RMB per 10 shares to all shareholders, based on a total of 150,680,000 shares[4]. - The cash dividend for 2018 was 1.10 yuan per 10 shares, amounting to 16,575,020 yuan (including tax)[119]. - The cash dividend for 2017 was 1.00 yuan per 10 shares, totaling 15,000,000 yuan (including tax)[119]. - The cash dividend in 2019 accounted for 23.71% of the net profit attributable to ordinary shareholders[120]. Research and Development - Research and development investment for 2019 was CNY 24.17 million, with a total of 30 patents obtained during the period[43]. - The company has a professional R&D team of 93 members, enabling it to respond quickly to market demands and develop new products[39]. - The company is currently in the trial production phase for several new products, including soft foam silicone oil and reactive flame-retardant polyether products[64]. - The company aims to develop high-performance, high-value-added fine chemical products, supported by various national development plans[99]. - The company plans to increase R&D investment in polyurethane catalysts, which are crucial for the development of the polyurethane industry, thereby ensuring sustained demand[106]. Market Expansion and Strategy - The company aims to expand the production scale of surfactants, flame retardants, and polyurethane functional additives to meet the growing market demand over the next three years[105]. - The company plans to expand its market presence in Southeast Asia, targeting a 25% increase in market share within the next three years[126]. - A strategic acquisition of a local competitor was announced, expected to enhance production capacity by 30% and reduce operational costs[127]. - The company is committed to expanding its market presence and enhancing its product offerings through ongoing research and development initiatives[80]. - The company is focused on expanding its market presence and enhancing competitiveness through strategic partnerships and technological advancements[98]. Risk Management - The company emphasizes the importance of risk awareness regarding future plans and forecasts, as detailed in the section on potential operational risks[4]. - The company acknowledges risks related to product liability claims and the potential impact on its business and reputation[112]. - The company faces risks associated with the transportation of hazardous chemicals, which could affect its raw material supply[112]. - The company recognizes the risk of intensified market competition due to the rapid growth of the fine chemical industry and plans to increase R&D investment to meet customer demands[148]. Financial Management - The company has implemented a fundraising management system to ensure that raised funds are properly allocated and managed[148]. - The company plans to enhance the efficiency of fund utilization from the fundraising projects to achieve expected benefits and improve profitability[149]. - The company is committed to maintaining a low-risk profile in its financial management activities[189]. - The company has reported a total of 1,000 million yuan in fixed-income products with an annualized return of 4.00%[190]. Corporate Governance - The company strictly fulfilled the share restriction commitments made during the initial public offering, with the commitment period lasting from February 13, 2017, to February 13, 2020[121]. - The company commits to comply with relevant laws and regulations regarding share reduction during the lock-up period[125]. - The company will stop paying salaries to directors and senior management who fail to fulfill their commitments for 10 trading days[140]. - The company guarantees to assume compensation responsibilities for any losses caused to investors due to unfulfilled commitments[155]. Environmental Commitment - The company has implemented measures to control pollution and improve environmental protection in its production processes[112]. - The company is committed to sustainability initiatives, with a goal to reduce carbon emissions by 30% over the next five years[162]. - The company is dedicated to advancing its silicone rubber project, expanding its applications in emerging fields such as electronics and renewable energy[106]. Subsidiaries and Investments - The company has established two new subsidiaries in 2019: Nanjing Chenhua New Materials Technology Co., Ltd. and Yangzhou Chenhua New Materials Sales Co., Ltd., which were included in the consolidated financial statements for the year[171]. - The company made a significant equity investment of ¥62,844,500.00 in Huai'an Chenhua New Materials Co., Ltd., acquiring a 100% stake[79]. - The company has not made any significant equity investments during the reporting period, focusing instead on internal growth and project development[81].

扬州晨化新材料股份有限公司 2019 年第三季度报告全文 扬州晨化新材料股份有限公司 2019 年第三季度报告 2019-100 2019 年 10 月 1 扬州晨化新材料股份有限公司 2019 年第三季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 扬州晨化新材料股份有限公司 2019 年第三季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期末 | 上年度末 | | 本报告期末比上年度末增减 | | --- | --- | --- | --- | --- | | 总资产（元） | 980,350,778.86 | | 893,032,948.07 | 9.78% | | 归属于上市公司股东的净资产 | 812,943,122.69 | | 755,340,368.90 | 7.63% | | （元） | | | | | | | 本报告期 | ...